About us Our members Our work Our governance Be an industry partner

Operational Committee

The Operational Committee comprises of 14 highly active members, including those who sit on the CLLAN Steering Committee, and one representative of each major industry partner. The Committee will act as a senior guiding force, shapingand guiding the Task Force and its activities

Objectives and Responsibilities

Objective

Act as a senior guiding force and advisory council for the CLL IC Task Force, shaping and guiding all initiatives and making strategic decisions about thedirection and priorities of the Task Force.

Responsibilities

All members of the Operational Committee are required to:

• Join two virtual meetings over 2025 and 2026 to discuss actions andactivities to approve Working Group projects and review progress towards overarching aim of the Task Force
• Provide written feedback and scrutiny on deliverables stemming from the Working Groups at key milestones to ensure that they represent anobjective, multidisciplinary consensus
• Endorse and widely disseminate core externally facing deliverables and giveconsent for their involvement to be published

Members of the Operational Committee

Chair

Nick York: Patient Engagement Officer, Leukaemia Care and CLLANSteering Committee Member and Chair Emeritus

Members

• Prof Stephen Opat: Co-chair of the Advocacy Working Group
•  Jana Pelouchova: Co-chair of the Advocacy Working Group
• Prof Paul Moss: Professor and Deputy Head, College of Medical and DentalSciences, University of Birmingham
• Prof John Seymour: Director of the Haematology Department, PeterMacCallum Cancer Centre & the Royal Melbourne Hospital
• Apendavyo Mshana: Founder, CLL Patient Support Group Tanzania;Executive Secretary, Blood Cancer Foundation of Tanzania
• Lorna Warwick: CEO, Lymphoma Coalition
• Andrielle Yost: Associate Director, Public Sector Engagement, The MaxFoundation
• Prof Norah Akinola: Haematologist, Department of Haematology and BloodTransfusion, Obafemi Awolowo University and Teaching Hospitals Complex,
  Ile-Ife
• Deborah Henderson OAM: Director, Henderson Media Group
• Prof Paolo Ghia: President, ERIC Raymond Vles: Chair, CLL Canada
• Dr Catherine Moura: CEO, Abrale – Brazilian Lymphoma and LeukemiaAssociation and Abrasta – Brazilian Association of Thalassemia
• Pierre Aumont: Administrator, ELLyE and Member and Vice Chair, CLLANSteering Committee
• Megan Yuan: AstraZeneca
• Helena Hjertonsson: Takeda

For specific queries, please contact: CLLICTaskforce@mhpgroup.com